THE USE OF ERYTHROPOIETIN IN A JEHOVAHS-WITNESS UNDERGOING MAJOR SURGERY AND CHEMOTHERAPY

被引:10
作者
JOHNSON, PWM [1 ]
KING, R [1 ]
SLEVIN, ML [1 ]
WHITE, H [1 ]
机构
[1] HOMERTON HOSP, LONDON E9, ENGLAND
关键词
D O I
10.1038/bjc.1991.111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:476 / 476
页数:1
相关论文
共 5 条
[1]   BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].
CASATI, S ;
PASSERINI, P ;
CAMPISE, MR ;
GRAZIANI, G ;
CESANA, B ;
PERISIC, M ;
PONTICELLI, C .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020
[2]   CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].
ESCHBACH, JW ;
EGRIE, JC ;
DOWNING, MR ;
BROWNE, JK ;
ADAMSON, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78
[3]  
GOODNOUGH LT, 1988, BLOOD S, V72, pA118
[4]  
MEANS RT, 1987, BLOOD S, V70, pA139
[5]   EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT-DNA ON THE ANEMIA OF PATIENTS MAINTAINED BY CHRONIC-HEMODIALYSIS [J].
WINEARLS, CG ;
PIPPARD, MJ ;
DOWNING, MR ;
OLIVER, DO ;
REID, C ;
COTES, PM .
LANCET, 1986, 2 (8517) :1175-1178